Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study - Concepedia

Concepedia

Publication | Open Access

Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study

DOI Full Paper Access

189

Citations

18

References

2011

Year

Raymond Osborne, Virginia L. Filiaci, Julian C. Schink, Robert S. Mannel, Angeles Alvarez Secord, Joseph L. Kelley, Diane Provencher, David S. Miller, Allan Covens, Janice M. Lage

Journal of Clinical Oncology

Abstract

The biweekly dactinomycin regimen has a higher CR rate than the weekly IM methotrexate regimen in low-risk GTN, a generally curable disease.

References

	Year	Citations
Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000 Iain A. McNeish, Sarah Strickland, L. Holden, Journal of Clinical Oncology	2002	245
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. G.J.S. Rustin, E.S. Newlands, Jean Michel Lutz, Journal of Clinical Oncology	1996	184
The role of low‐dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT) K. D. Bagshawe, J. Dent, E.S. Newlands, BJOG An International Journal of Obstetrics & Gynaecology	1989	146
Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors John R. Lurain, Elizabeth P. Elfstrand American Journal of Obstetrics and Gynecology Surgical OncologyMedicineMetronomic TherapySingle-agent Methotrexate ChemotherapyGynecology	1995	103
Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy John P. Roberts, John R. Lurain American Journal of Obstetrics and Gynecology Surgical OncologyMedicineMetronomic TherapyGynecologySingle-agent Chemotherapy	1996	91
The Power Function of the "Exact" Test for Comparing Two Binomial Distributions John T. Casagrande, Malcolm C. Pike, Peter G. Smith Journal of the Royal Statistical Society Series C (Applied Statistics) StatisticsBinomial DistributionsPower Function	1978	89
5-Day Methotrexate for Women with Metastatic Gestational Trophoblastic Disease John T. Soper, Daniel L. Clarke‐Pearson, Andrew Berchuck, Gynecologic Oncology HematologyReproductive HealthGynecologyMaternal HealthMaternal-fetal Medicine	1994	88
Actinomycin D as the primary agent for gestational trophoblastic disease Rapin Osathanondh, Donald P. Goldstein, G B Pastorfide Cancer Actinomycin DSurgical OncologyHealth SciencesTriple TherapyMedicine	1975	77
Treatment of nonmetastatic gestational trophoblastic disease: Results of methotrexate alone versus methotrexate-folinic acid Ellen Blair Smith, John C. Weed, Lee Tyrey, American Journal of Obstetrics and Gynecology HematologyGynecologyMaternal HealthMaternal-fetal MedicineFetal Complication	1982	77
Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease: A prospective phase II trial of the gynecologic oncology group Edmund S. Petrilli, Leo B. Twiggs, John A. Blessing, Cancer OncologySingle-dose Actinomycin-d TreatmentPulse SchedulingMetronomic TherapyGynecology	1987	68

Page 1